secwatch.observer — SEC 8-K summary
======================================

Issuer:     22nd Century Group, Inc. (XXII)
CIK:        0001347858
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0001104659-21-107566
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

22nd Century Group appoints Anthony Johnson to Board of Directors
-----------------------------------------------------------------

- Anthony Johnson appointed as Class II director effective August 18, 2021.
- Johnson is co-founder, President, CEO of Kodikaz Therapeutic Solutions and founding partner of Buffalo Biosciences.
- Will serve on Scientific, Finance and Compensation Committees; receives standard non-employee director compensation.
- Bring experience in biotechnology, genomics, and life sciences; held roles at Empire Genomics and Thermo Fisher.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/0001104659-21-107566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/tm2125456d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-107566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer